News

Scientific articles based on Horizon 2020 funded research must be made available for free, says the Commssion. But there will be an exception for commercially sensitive raw data

Members of the European Parliament assess the strengths and weaknesses - and question aspects of the Commission’s Horizon 2020 plan

The patent ruling in a financial case raises questions about the decision to invalidate two personalised medicines patents in the Prometheus case, says Rouget F. (Ric) Henschel

Brussels should deal only with the broad overarching strategy of the EU’s R&D agenda, with new scientific steering committees appointed to see to the details, key MEPs tell Science|Business

EU lawmakers want leading figures in Europe’s research and innovation programmes to make regular appearances before Parliament, influential MEPs tell Science|Business

MEPs say the European Commission’s proposed flat rate funding scheme is an over-simplification that will favour industry over academics

Strasbourg should become the EU’s innovation capital, say MEPs. The proposal is an attempt to break the deadlock with France about the seat of the European Parliament

MEPs say work is still needed to strike the balance between flexibility, coherence and reliability

MEPs call for better organisation in this aspect of Horizon 2020 to ensure it meets its goals

The EIT needs to do more to be seen as a global brand of excellence, say MEPs